Abstract
Obesity is considered one of the risk factors for metabolic disorders such as diabetes mellitus. There is increasing evidence that obesity and diabetes are under the control of numerous cytokines and hormones, such as adiponectin and leptin. In addition, a number of studies have revealed that the brain functions play a role in the development of obesity and diabetes mellitus. Histamine and its receptors are classical inflammatory mediators in peripheral tissues and also function in the brain. The results of physiological and pharmacological studies revealed that brain histamine and its receptors are involved in the regulation of obesity and diabetes mellitus. Leptin has been shown to regulate obesity and diabetes partially via brain histamine and its receptors. In this review, we focused on the roles of brain histamine and its receptors in regulating obesity and diabetes mellitus.
Keywords: Histamine, Obesity, Histamine H1 receptors, Histamine H3 receptors, Diabetes
Current Diabetes Reviews
Title: Neuronal Histamine and its Receptors in Obesity and Diabetes
Volume: 3 Issue: 3
Author(s): Takayuki Masaki and Hironobu Yoshimatsu
Affiliation:
Keywords: Histamine, Obesity, Histamine H1 receptors, Histamine H3 receptors, Diabetes
Abstract: Obesity is considered one of the risk factors for metabolic disorders such as diabetes mellitus. There is increasing evidence that obesity and diabetes are under the control of numerous cytokines and hormones, such as adiponectin and leptin. In addition, a number of studies have revealed that the brain functions play a role in the development of obesity and diabetes mellitus. Histamine and its receptors are classical inflammatory mediators in peripheral tissues and also function in the brain. The results of physiological and pharmacological studies revealed that brain histamine and its receptors are involved in the regulation of obesity and diabetes mellitus. Leptin has been shown to regulate obesity and diabetes partially via brain histamine and its receptors. In this review, we focused on the roles of brain histamine and its receptors in regulating obesity and diabetes mellitus.
Export Options
About this article
Cite this article as:
Takayuki Masaki and Hironobu Yoshimatsu , Neuronal Histamine and its Receptors in Obesity and Diabetes, Current Diabetes Reviews 2007; 3 (3) . https://dx.doi.org/10.2174/157339907781369002
DOI https://dx.doi.org/10.2174/157339907781369002 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Fixed Combination Efficacy Assessment in Patients with Secondary Neovascular Glaucoma and Diabetes Mellitus
Current Diabetes Reviews Design and Synthesis of Thiazolidinedione Derivates as Selective PPARγ Modulators
Letters in Drug Design & Discovery Subject Index to Volume 1
Current Vascular Pharmacology p38 MAP Kinase Interacts with and Stabilizes Pancreatic and Duodenal Homeobox-1
Current Molecular Medicine Fluoride Interactions: From Molecules to Disease
Current Signal Transduction Therapy Antidiabetic Potential of Silver/Chitosan/Ascorbic Acid Nanocomposites
Current Nanomedicine Preparing for Pregnancy: A Body Weight Perspective and Update of the Literature
Current Nutrition & Food Science Free Radicals Generated by Post-Prandial Oxidative Burst in the Early Alterations of Vascular Contractility
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Postoperative Atrial Fibrillation - What Do We Really Know?
Current Vascular Pharmacology Diet Bioactive Compounds: Implications for Oxidative Stress and Inflammation in the Vascular System
Endocrine, Metabolic & Immune Disorders - Drug Targets Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Current Nanoscience Important Aspects of Post-Prandial Antidiabetic Drug, Acarbose
Current Topics in Medicinal Chemistry Management of Exercise-induced Glycemic Imbalances in Type 1 Diabetes
Current Diabetes Reviews Insulin Secreted From Genetically Engineered Intestinal Cells Reduces Blood Glucose Levels in Diabetic Mice
Current Gene Therapy “Actin”g on GLUT4: Membrane & Cytoskeletal Components of Insulin Action
Current Diabetes Reviews Immunization Against Active Ghrelin Using Virus-Like Particles for Obesity Treatment
Current Pharmaceutical Design The Pharmacology of Diabetic Complications
Current Medicinal Chemistry Targeting Dyslipidemia in the Metabolic Syndrome: An Update
Current Vascular Pharmacology Impact of Computational Structure-Based Predictive Toxicology in Drug Discovery
Combinatorial Chemistry & High Throughput Screening Can Imaging Techniques Identify Smoking-Related Cardiovascular Disease?
Current Pharmaceutical Design